Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of ESOP: 332,450 shares05-07-2021
05-07-2021
Gland Pharma Ltd - 543245 - Earnings Conference Call
Earnings Call for Investors/Analysts to be held on Wednesday, July 21, 2021, at 1830 - 1930 hours IST.05-07-2021
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Notice of Board Meeting - Advertisement29-06-2021
Gland Pharma Ltd - 543245 - Board Meeting Intimation for Board Meeting Intimation For Quarterly Board Meeting
Gland Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/07/2021 ,inter alia, to consider and approve Board Meeting Intimation to consider and approve the Unaudited financial results for the quarter ended June 30, 202128-06-2021
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Meeting with Investec Capital Services28-06-2021
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Meeting with Investec Capital Services28-06-2021
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Meeting with Baring Asset Management28-06-2021
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Investor Meetings22-06-2021
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Investor meetings19-06-2021
Gland Pharma Ltd - 543245 - Disclosure Of Related Party Transactions For The Half Year Ended March 31, 2021
Disclosure of related party transactions for the half year ended March 31, 202119-06-2021